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Gross and Microscopic Lesions in the
Female SENCAR Mouse Skin and Lung in
Tumor Initiation and Promotion Studies
by Gary L. Knutsen,* Robert M. Kovatch,* and
Merrel Robinsont
The skin and lung tissues from SENCAR mice used as part of the Environmental Protection Agency's
(EPA's) Carcinogenesis Testing Matrix were examined. This study included SENCAR mice used in three
different short-term bioassay protocols in which the skin papilloma assay was used to identify initiators,
promotors, and complete carcinogens. Also included were the pathology findings from SENCAR mice used
in the combined bioassay in which the skin assay and the lung adenoma assay were conducted simulta-
neously. The gross and microscopic features of treatment-associated and spontaneous lesions of the skin
and lung ofthe SENCAR mouse used in these studies are defined and the lesions most commonly observed
are described.
Generally, gross observations and microscopic findings in both the skin and lung tissues were poorly
correlated. Although there are several definite criteria on which gross interpretations of the various skin
and lung lesions can be made, with the exception ofpedunculated squamous cell papillomas and the classic
squamous cellcarcinomas, thevarious lesiontypes had awidevariety ofclinical presentationsthatseverely
compromised the accuracy of gross diagnosis. Further, in the case of benign skin neoplasms, malignant
transformation of these tumors most often occurred at the base of the lesion and was initially hidden
from gross observation. As a result, approximately 50% of the neoplasms interpreted clinically as benign
tumors (papillomas and keratoacanthomas) were actually malignant neoplasms. Moreover, many lesions
determined grossly to be nontumorous were in fact found to be neoplastic when examined microscopically.
The SENCAR mouse was found to be more responsive in the lung adenoma assay than other strains
examined with exception of the Strain A. Although accurate interpretation of the lung lesions in the
SENCAR was compromised by nonneoplastic treatment-associated and/or spontaneous lesions, the fea-
sibility ofusing the SENCAR skin and lung as target tissues in two-stage combined carcinogenesis studies
merits further consideration.
Introduction
The concept oftwo-stage chemicalcarcinogenesis was
first identified by Berenblum (1) and Rous (2) in 1941.
Much of our understanding of the mechanisms of this
concept has been gained from the mouse skin papilloma
assay (3-6). Although a variety of strains of mice have
been used in the assay, the SENCAR mouse, a stock
bred specifically forits sensitivity totwo-stage skin car-
cinogenesis, has been most frequently used in these
studies. Slaga has shown the SENCAR mouse to be the
most sensitive mouse skin carcinogenesis systemforthe
identification of initiators, promotors, and more re-
cently, complete carcinogens (7). This sensitivity has
been confirmed by other investigators (8-10). Based on
these findings, the Environmental Protection Agency,
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Health Effects Research Laboratory (EPA/HERL), in-
cluded the SENCAR Skin Papilloma Assay in the bank
of short-term bioassays that make up the EPA's Car-
cinogenesis Testing Matrix, a program of Tier 2 bioas-
says designed to confirm the carcinogenic properties of
environmental chemicals and mixtures (11). Robinson
and others, in an attempt to consolidate several of the
assays and improve sensitivity (12), recently reported
the use ofthe SENCAR mouse in a combined bioassay
in which the skin papilloma assay was conducted si-
multaneously with a modified version of the lung ade-
noma assay, a test traditionally conducted in Strain A
mice (13,14).
Although the responsiveness of the SENCAR Skin
Papilloma Assay has been reviewed and is well docu-
mented for a wide variety ofchemicals (4,8-11,15), and
the sensitivity of the lung has been reported in the
SENCAR mouse for several chemicals (12), little infor-
mation has been published on the pathology of the le-
sions induced in both the skin and lung of SENCAR
mice in these assays. Moreover, most of the publishedKNUTSEN, KOVATCH, AND ROBINSON
pathology reports of skin carcinogenesis in the SEN-
CAR mouse have involved the microscopic confirmation
of a percentage of skin lesions as carcinomas or were
limited to those identified clinically as carcinomas.
There is a paucity of information concerning the diag-
nostic criteria on which gross observations were based,
and microscopically, classification ofthe skin neoplasms
in these reports was limited to "papilloma" and "carci-
noma." To date, no reports concerning the induced or
spontaneouslyoccurringpulmonarylesions ofSENCAR
mice have been published.
During the past 30 months, we have evaluated, by
both gross and microscopic examination, the skin and
lung tissues from more than 12,000 female SENCAR
mice as part ofthe EPA's Tier2 Matrix studies for two-
stage carcinogenesis. It is the purpose of this paper to
providediagnostic criteriaand morphologic descriptions
ofthe gross and microscopic treatment-induced lesions
in the SENCAR mouse skin and lung.
Materials and Methods
Experimental Design
The pathological findings described represent treat-
ment-induced lesions observed infemale SENCAR mice
usedin EPA's two-stage Carcinogenesis TestingMatrix
project. The four basic types of protocols used in the
SENCAR Matrix studies have been previously de-
scribed in detail (12,15-17) and included the following:
Protocol 1: initiation/promotion (tumor initiators) skin
papilloma assay; Protocol 2: initiation/promotion (pro-
moting agents) skin papilloma assay; Protocol 3: com-
plete carcinogenicity skin papilloma assay; Protocol 4:
combined bioassay; skin papilloma and lung adenoma
assays.
The first protocol, designed to test the initiating po-
tential of a substance, consisted of the exposure of fe-
male SENCAR mice to either single or multiple doses
of chemical or environmental mixture applied topically
or subcutaneously to the shaved dorsal skin of the
mouse. Two weeks following initiation, the promoting
agent, 12-O-tetradecanoylphorbol-13-acetate (TPA)
was administered (1 p,g/application in 0.2 mL acetone)
three times a week for 20 weeks. Protocol 2 was the
same, with the exception that a known initiator, ureth-
rane, was followed by 20 weeks ofapplication with the
suspected promotor. For Protocol 3, the test substance
was administered three times per week to the dorsal
skin of animals, either topically or subcutaneously, for
a period of 1 to 20 weeks to test for complete carcino-
genic properties. For the combined bioassay (Protocol
4), two days after a single dose of a known carcinogen
was administered by intraperitoneal injection, 1.0 ,ug
of TPA was applied three times a week for 20 weeks.
The appearance and regression of skin tumors were
chartedweeklyusing agrid systemwithletter and num-
ber coordinates to permit specific lesions tobe identified
by size and topography. For Protocols 1, 2, and 3, the
animals were typically sacrificed 12 months following
initiation or at approximately 14 months of age. The
animals were 36 weeks of age at sacrifice for the Com-
bined Bioassay studies.
Clinical Observations
Following quarantine of the mice, the test animals
were identified, weighed, shaved, and placed into treat-
ment groups. The mice were shaved weekly thereafter
to facilitate administering test compounds and lesion
observation. After the initial weighing, the animals
were weighed each week for 6 weeks, then monthly for
the duration of the study.
Duringthe courseofthe study, twodailyobservations
ofthe animals were made to check food and water and
to monitormorbidity. In addition, aweekly observation
was performed on all test animals during which all
grossly observed lesions were charted on a grid, and
the lesion type, location, and size were indexed. Based
on clinical observations and standardized morphologic
criteria, the lesions were placed by type into one offour
categories: papilloma, carcinoma, sore, and subcuta-
neouslesion. Allnontumorlesions, includingulcers, ero-
sions, etc., were categorized as sores. Lesions were
classified as subcutaneous ifthe skin overthe lesion was
intact. Duringthe weekly observations, alllesions iden-
tified as tumors were recorded and included in the daily
count. When tumors were observed for three consec-
utive weeks, the tumor counts were included in the
cumulative counts. All individual tumors were charted
weekly until they regressed or coalesced, or until the
animal either died or was sacrificed.
Test Animals
Female SENCAR mice, from 5 to 8 weeks of age,
were obtained from Harlan Sprague-Dawley Inc. (In-
dianapolis, IN). The animals were quarantined at the
EPA facility for a maximum of 2 weeks. Mice were
placed on study when the majority ofmice were in the
resting stage of the hair growth cycle. Depending on
protocol, the animals were divided into groups of20 to
40 animals and housed 10/cage. Water and Purina Lab
chow were provided ad libitum.
Necropsy
A complete necropsy was performed for all sponta-
neous deaths, moribund sacrifices, and the scheduled
terminal sacrifice. Grossobservations ofall externaland
internal lesions were recorded on specially designed ne-
cropsy forms that enabled the individual skin lesions to
be specificallydocumentedbynumber, size, andlocation
on the carcass. At least one photograph was taken of
each animal to demonstrate each skin lesion and other
representative internal gross lesions. Necropsy in-
cluded examination and fixation of 41 tissues, which,
alongwith the carcass, were placed in 10% neutral buff-
ered formalin. In all studies, the lungs were removed
intact, examined for lesions, and perfused to approxi-
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mate tidal volume, after which the trachea was ligated.
The individual skin lesions were prosected and placed
into cassettes to maintainidentity. Additionally, apiece
of "normal" dorsum skin was also obtained from each
mouse. All skin tissues were stretched and mounted on
filter paper before fixation.
Histopathology
Microscopic evaluation oftissues for all protocols was
limited to the dorsal treatment area, all grossly rec-
ognized skin lesions up to six per animal, and all other
lesions observed as abnormal either at necropsy or dur-
ing tissue trimming. In those animals in which multiple
skin lesions were present, each lesion was trimmed and
processed in a separate cassette to maintain identity of
the lesion for subsequent correlation with both clinical
observations and necropsy findings. In the combined
bioassay, a Shimkin adenoma assay was conducted (13).
The lobes ofthe lungwere separated, lesions consistent
with primary lung tumors were counted and tabulated,
and each lesion was recorded topographically on lung
count forms. This task was performed by two techni-
cians working independently of each other. Significant
discrepancies were further examined by either the pa-
thologist or a third technician. Unresolved discrepan-
cies, all gross lesions of questionable diagnosis, and at
least 10% of the lung tumors were examined micro-
scopically for lesion confirmation and/or diagnosis.
The identity of each skin lesion was maintained
throughout theprocesstoenablesubsequent correlation
of the microscopic findings with the gross observation
at necropsy and previous clinical findings. These data
were subsequently analyzed to determine the accuracy
ofskin lesion diagnoses based on gross interpretations.
All microscopic diagnoses were entered into a comput-
erized pathology data system that generated the inci-
dence tables for individual animals and summary tables
for all animals.
Results and Discussion
Gross and Microscopic Lesions of the Skin
and Subcutis
Samples of skin tissues removed from the dorsal
treatment area and all skin lesions from more than
12,000 SENCAR mice used in EPA's Matrix studies
were examined grossly at necropsy and during tissue
trimming and were then evaluated by light microscopy.
A wide variety ofinflammatory, hyperplastic, and neo-
plastic lesions were observed in the animals. A list of
these lesions, separated into general morphologic clas-
sifications, is shown in Table 1. The vast majority of
these lesions were very likely treatment-induced with
the exception of focal inflammatory and hyperplastic
lesions confined to the epidermis and immediately ad-
jacentdermis and severalneoplasms ofthe subcutisthat
were probably naturally occurring.
Nonneoplastic Lesions of the Skin and Subcutis.
Neoplasms
Epidermal neoplasms
Squamous cell papilloma
Pedunculated
Sessile (broad based)
Keratoacanthoma
Squamous cell carcinoma
Keratinizing
Nonkeratinizing
Anaplastic
Basal cell tumor
Neoplasms of the subcutis
Fibroma
Fibrosarcoma
Rhabdomyosarcoma
Plasma cell tumor
Sarcoma, NOS
Malignant lymphoma
Mammary gland neoplasms
Adenoma
Adenocarcinoma
Adenoacanthoma
Nonneoplastic lesions
Epithelial hyperplasia
(acanthosis, hyperkeratosis,
parakeratosis)
Inflammation (acute, subacute,
chronic, chronic-active)
Erosion
Ulceration
Epidermal inclusion cyst
Myeloid hyperplasia
Amyloid
The most frequently occurringlesion involvingthe skin/
subcutis in treated animals was inflammation and hy-
perplasia of the epidermis and dermis. These changes
varied from small focal areas of acute inflammation to
extensive erosive and/or ulcerative areas accompanied
by varying amounts ofepithelialhyperplasia, consisting
of acanthosis, hyperkeratosis,and parakeratosis (Fig.
1). Theepidermal rete pegs, consistingofwellorganized
fingerlike projections ofhyperplastic epithelial cells, ex-
tended into the dermis and occasionally into the sub-
cutis. Generally, the hyperplastic response was asso-
ciated with varying amounts of chronic-active
inflammation with abundant amounts of keratinaceous
debris usually present on the epidermal surface. On
gross examination, these lesions were clinically re-
corded as sores, and were characterized by loss ofhair
FIGURE 1. Epithelial hyperplasia. Area of severe epithelial hyper-
plasia consisting of acanthosis and hyperkeratosis with inflam-
mation ofthe dermis and subcutis. Normal skin is observed at the
left margin of the lesion (H & E, x26).
Table 1. Classification of lesions of the skin and subcutis in
female SENCAR mice.
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over what was usually a dry, crusty, slightly raised
lesion that may or may not have been ulcerated. The
margin of the lesion showed a smooth transition as it
blended into the adjacent normal skin.
Focal areas ofinflammation and hyperplasia were ob-
servedinnontreated micebutnevertotheextentshown
in Figure 1. The small, focal lesions often represented
inflammatory response to bite wounds or other local
irritation. Other large areas of uniform epithelial hy-
perplasia not accompanied by either ulceration or in-
flammationwere alsoobserved. Theselesionswere very
likely naturally occurring; however, the development of
hyperplasia in response to continued shaving merits
consideration. Inthis paperwe provide evidence forthe
development of neoplasms from hyperplastic lesions, a
progression that has been previously documented in
mouse skin carcinogenesis studies (18-20). Since we
have diagnosed squamous cell papillomas in nontreated
mice, it isassumed that atleast some ofthe hyperplastic
lesions also occurred spontaneously in the SENCAR
mouse.
Another nonneoplastic lesion of the skin, the epider-
mal inclusion cyst defined by Bogovsky (19), was com-
monly observed in treated animals and in a few of the
nontreated mice. The incidence ofthese cysts increased
with the severity of skin ulceration and the amount of
active inflammation. The skin generallyremained intact
over these lesions, and they appeared clinically as sub-
cutaneous raised areas ornodules. Inthose cases where
the skin surface was interrupted, the lesion was occa-
sionally misinterpreted as a skin neoplasm. In several
instances, the usually thin layer ofepithelial cells lining
the cystappeared toundergo malignanttransformation,
and a squamous cell carcinoma was observed within the
cyst. If the skin surface remained intact, the latter le-
sion was not detected clinically.
Ahigh percentage ofthe treated mice had aggregates
ofcellular infiltrates in the subcutis consisting ofeither
plasma cells or loosely arranged aggregates of mature
and immature cells ofthe granulocyte series. The latter
lesion, diagnosed as myeloid granulocytic hyperplasia,
was a proliferative change that is often systemic and is
commonly seen in mouse skin paint studies. Histori-
cally, this lesion has often been misinterpreted as gran-
ulocytic leukemia. The differential features of myeloid
hyperplasia versus granulocytic leukemia has been dis-
cussed recently by Long (21).
The final nonneoplastic lesion observed in the skin
was deposition of amyloid in the dermis immediately
adjacent to the basement membrane of the epidermis.
This deposition occurred in association with varying
amounts of epidermal hyperplasia and was usually ac-
companied by mild, chronic inflammation ofthe dermis
and subcutis consisting of lymphocytes, macrophages,
and varying numbers of plasma cells. The presence of
amyloid in the skin is not an unexpected finding, es-
pecially since Kovatch (22) has reported amyloid dep-
osition in a wide range of tissues in both treated and
nontreated SENCAR mice.
Lesions of the adnexal structures of the skin were
FIGURE 2. Squamous cell papilloma. Single sessile papilloma in a
SENCAR mousewithkeratinized, cauliflower-like protuberances.
lacking, with the exception offocal inflammation ofhair
follicles. Although small foci of sebaceous cell differ-
entiation were present in several of the skin tumors,
hyperplastic lesions of the sebaceous glands were not
observed.
Neoplastic Lesions ofthe Skin andSubcutis. The
most frequently occurring benign neoplasm of the skin
observed in the SENCAR Matrix studies was the squa-
mous cell papilloma. This tumor had a variety ofclinical
presentations and varied in size from 0.1 cm to greater
than2.0 cmindiameter. Thepapillomasprojected above
the surface of the skin either as keratinized, pointed
protuberances oraslobulated, cauliflower-like growths.
The tumors were red to dark tan and had dry, rough,
and finely fissured surfaces (Fig. 2). Papillomas were
classified into two types by the morphologic features of
their attachment to the skin; either pedunculated, hav-
ing a thin stalk, or sessile, having a broad base with a
height less than the diameter ofthe attachment. Gross
examination and palpation of the pedunculated lesion
revealed the lesion to be a knoblike growth attached by
a stalk of variable thickness with the base of the stalk
attachment blending evenly with the skin surface. The
broad-based papillomas were more difficult to palpate,
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FIGURE 3. Squamous cell papilloma. Typical sessile (broad based)
squamous cellpapillomawith the diameterofthe base ofthe tumor
greater than the height (H & E, x26).
but important diagnostic information was gained by
carefully examining the base of the lesion for any ir-
regular growths, acute inflammation, hyperemia, swell-
ing, and/or adherence to the underlying tissue, all of
which are indications of malignancy.
Microscopically, the twotypesofpapillomas consisted
of similar components but were easily differentiated.
Thepedunculatedpapillomashadanouterlayerofthick-
ened, relatively regular, but folded, hyperplastic epi-
dermis capped by varying amounts of keratinized cells
and keratinaceous debris. This layer, 10 to 20 epithelial
cells thick, rested on an inner layer ofconnective tissue
stroma. The dermis within the stalk was often more
fibrous and denser than normal, and it generally con-
tained minimal to occasionally severe inflammatory cell
infiltrates. The broad-based papilloma (Fig. 3) had sim-
ilar components, but the lesion lacked a stalk and was
less protuberant, having aheightless thanthe diameter
ofthe base oftheneoplasm. Inboth types ofpapillomas,
the cells of the stratum granulosum of the epithelium
were often arranged inregular masses, with ridges that
were oftenseverelyelongated and that extended deeply
into the dermis. The base of the rete ridges was well
organized, and the cells were clearly demarcated from
the adjacent dermis without interruption of the base-
ment membrane (Fig. 4). The neoplasms contained few
mitotic figures, and the cells were ofsimilar size, shape,
and staining qualities. Sectioning artifacts must be con-
sidered when examining the base of these lesions, the
site where malignant changes most frequently occur.
Sometimes nests ofcells appeared to be separated from
the rete pegs, suggesting metastases, but close exam-
ination of the cell size, shape, and staining properties
indicated that the cell clusters did not represent early
metastases but occurred rather as a function of cut.
The second type ofbenign neoplasm ofepithelial cell
origin commonly observed in SENCAR mice was ker-
atoacanthoma. Theseneoplasms, referredtoasinverted
papillomas, developed in the dermis and arose from the
FIGURE 4. Squamous cell papilloma. Base ofthe sessile papilloma
in Fig. 3. The base ofthe rete ridges are well organized and there
is no interruption of the basement membrane (H & E, x260).
epithelial cells associated with hair follicles. The kera-
toacanthomas observed in the Matrix studies presented
a wide variety of gross appearances. Most frequently,
these neoplasms were crater-like and were filled with
keratin and surrounded by an irregular lip of abruptly
reflexed and compressed epidermis (Fig. 5). Keratoa-
canthomas were generally irregularly round, and when
situated superficially on the skin, the lesion, which had
a bud-like appearance, pushed completely above the
surface and rested on an appendage ofstroma in a man-
ner similar to pedunculated papillomas. As reported by
Bogovsky, the keratoacanthoma is not always easily
distinguishable fromthe papilloma. It is speculated that
in these cases, the glabrous epidermis and the epithe-
lium associated with the hair follicle simultaneously re-
spond to the carcinogenic action ofthe same agent (19).
Ghadially (23,24) identified three types of keratoa-
canthomas in the mouse. Type 1 neoplasms arose from
the upper part of the hair follicle, and types 2 and 3
developed from the lower part. Although we have not
routinely attempted to characterize keratoacanthomas
as to type, it is our experience that approximately half
of these neoplasms in SENCAR mice are consistent
with Ghadially's type 1 tumor, in that they were su-
perficially located and often pedunculated. The remain-
derofthe keratoacanthomas were embedded inthe skin
as shown in Figure 5. These neoplasms, consistent with
the type 3 tumors described by Ghadially, were clini-
cally more difficult to diagnose and were often misin-
terpreted as ulcers or, in some cases, as small squamous
cell carcinomas.
Descriptions such as "cup- or berry-shaped," com-
monly used to describe keratoacanthomas, were best
appreciated when the lesions were examined micro-
scopically (Fig. 6). The sides ofthe tumor were convex
and were composed of sheets of compressed epithelial
cells. Generally, the central core ofthe lesion was filled
withlaminatedkeratininterruptedonlybyanoccasional
frond ofepithelial cells. Unlike papillomas, the amount
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FIGURE 6. Keratoacanthoma. Classic cup-shaped keratoacan-
thoma. There is sharp demarcation between the margins of the
tumor and the adjacent subcutaneous tissue (H & E, x26).
FIGURE 5. Keratoacanthoma. Irregularly round slightly raised
neoplasm having a central crater surrounded by an elevated rim
ofepidermal tissue.
ofkeratin and keratinaceous debris wasusually the pre-
dominant component in these lesions. Both trichohya-
line and keratohyaline granules were seen in the epi-
thelium. The base of the lesion was situated either in
the dermis or subcutis, often resulting in marked dis-
placement and compression of the stroma. This lesion
differs from the squamous cell papilloma in that the
dermis immediately beneath the papilloma was usually
thicker and denser. In both papillomas and the kera-
toacanthomas, malignant transformation was observed
to occur most often at the base ofthe neoplasms. Early
transformation was characterized by penetration ofthe
compressed dermis and invasion ofthe muscle layer by
nests of irregular cells, distinguished by showing var-
iation in size, shape, and staining qualities. These
changes, since they frequently occurred at the base of
the tumor and were hidden from gross observation,
were seldom diagnosed as malignant lesions except in
those cases where significant new tumor growth had
pushed to the surface ofthe skin, causing an elevation
ofthe peripheral portions of the tumors.
A review of the clinical and pathological data gen-
erated by several ofthe EPA's Matrix studies indicated
thatthere was adirect correlationbetweenthe severity
ofulceration during the initial stages ofpromotion and
the incidence of keratoacanthomas. Although the dose
of TPA administered in the various Matrix studies did
not change, some inconsistency was observed in the
response ofthe skin to promotion. In shipments ofmice
in which there was early and persistent ulceration in
response to promotion, the incidence ofkeratoacantho-
mas increased significantly and approximated the num-
berofsquamouscellpapillomasthatdeveloped. Inthese
cases, the malignant transformation of keratoacantho-
mas was also increased.
The neoplasm with the most variable gross appear-
ance was the squamous cell carcinoma. The classic fea-
tures of a carcinoma are shown in Figure 7. These neo-
plasms arose from pre-existing papillomas,
keratoacanthomas, or epidermal inclusion cysts devel-
oped spontaneously within the epidermis, initially as
carcinoma in situ, or developed in association with ul-
cers. Ifthe carcinomas are examined microscopically in
the early stages of tumor development, the origin of
the lesion can be determined. The most consistent fea-
tures observed in the carcinomas in our studies were
severe ulceration, crater formation, and rapid growth.
The last feature was typically demonstrated by a rapid
and striking elevation ofthe margins ofthe tumor, with
the borders becoming indurated and poorly defined.
Based onmicroscopicfeaturesoftheneoplasms, three
types ofsquamous cellcarcinomas havebeenpreviously
identified: (1) keratinizing, (2) nonkeratinizing, and (3)
anaplastic (19). The appearance ofthese neoplasms was
greatly influenced by the origin ofthe malignant lesion.
In the EPA Matrix studies, the majority of the carci-
nomas that developed were keratinizing types. How-
ever, it is our experience that the factors that affected
the development of keratoacanthomas similarly influ-
enced the type of carcinoma that developed. Those an-
imalswithinitiallysevereulcerationpersistingthrough-
out the promotion phase developed carcinomas that
were invariably less keratinized and more anaplastic.
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FIGURE 7. Squamous cell carcinoma. Carcinoma with crater for-
mation, central ulceration with the margins formed by a rim of
elevated malignant epidermal tissue.
In these cases, the carcinomas appeared to develop
morefrequently, eitherfromulcers orfromwithin areas
ofepidermal hyperplasia, and withoutevidencethat any
benign tumors were present before the carcinoma de-
veloped.
Carcinomas developing from papillomas, keratoacan-
thomas, orepidermalhyperplasiawerekeratinized-type
carcinomas, comprising differentiated and undifferen-
tiated squamous cells arranged in cords or whorls with
keratinized orpartiallykeratinized centers (Fig. 8). The
cords or fingerlike trabeculae extended into the under-
lying dermis, subcutis, and often into the subcutaneous
muscle layers and vessels. The cells of these tumors
were irregular in shape and size, and the nuclei were
generally round or oval and ofvarying dimensions. The
cellstypically stained withvaryingintensity, withthose
cells at the margins ofthe neoplasms often being atyp-
ical, hypertrophied, and stained pink to brightly eosi-
nophilic. As the carcinomas became less keratinized and
more anaplastic, mitotic activity was increased, kera-
tinization of single cells became more frequent, and in-
tercellular bridges, commonly observed in well differ-
entiated carcinomas, were more difficult to find. Figure
9 demonstrates an atypical squamous cell carcinoma.
FIGURE 8. Squamous cell carcinoma. Differentiated and undiffer-
entiated squamous cells are arranged inirregular cords andwhorls
with keratinized and partially keratinized centers (H & E, x260).
Poorly developed keratinized squamous elements and
aggregates of atypical epithelial cells were observed,
but the predominant cellular structures were the irreg-
ular whorls of poorly differentiated, elongated cells.
These structures appeared to be forming rudimentary
hair follicles with, occasionally, one to several cells in
the central core undergoing keratinization.
Associated with the vast majority of carcinomas, re-
gardless of type, was a moderate to severe chronic-
active inflammatory process consisting ofa mixed pop-
ulation of inflammatory cells and varying amounts of
fibrosis. In some cases, there was a striking desmo-
plasticresponse, withthereactive connectivetissue ele-
mentsbeingthepredominant structureintheneoplasm.
Occasionally, the connective tissue elements ofthe neo-
plasms were highly irregular, poorly organized, and
without orientation. Figure 10 shows such a neoplasin
in which the sarcomatous-appearing stromal element
FIGURE 9. Squamous cell carcinoma. Anaplastic squamouscell car-
cinoma with irregular whorls of poorly differentiated elongated
cells. Cells appear to be forming rudimentary hair follicles with
keratinization of the core (H & E, x260).
97KNUTSEN, KOVATCH, AND ROBINSON
FIGURE 10. Squamous cell carcinoma. Carcinoma in which the sar-
comatous appearing stromal element ofthe neoplasm occupies the
majority of the lesion (H & E, x 52).
occupies most of the lesion. In several cases, both the
epithelial and the connective tissue elements appeared
to have undergone malignant transformation, and car-
cinosarcoma was diagnosed. The pathogenesis ofa neo-
plasmofthistype is not understood. This neoplasmmay
represent two separate and distinct neoplasms that
arise simultaneously or may represent a fibroepithe-
lioma as described by Pinkus (25).
As was the case for several other types of tumors
previously discussed, the carcinosarcomas appeared to
develop only in those animals which had persistent ul-
ceration in response to either the promotor or initiator.
The presence ofulceration may have allowed for direct
contact ofthe initiator or promotor with the underlying
dermis. Clinically, most ofthese tumors were diagnosed
as sores and there was no evidence of a tissue change
other than ulceration (Fig. 11). The prominent fleshy
rimoftumorgrowthnormallyassociated with squamous
cell carcinomas was missing.
Interestingly, these lesions were observed only in
SENCAR mice that were sacrificed terminally (13
months of age) and not in any animals that died early
in the study. This observation is in agreement with
findingsinwhole-life mouseskinpaintstudiesconducted
in other laboratories (W. Sheldon, National Center for
Toxicological Research, personal communication), stud-
ies in which, with time, fewer carcinomas were ob-
served, and sarcomas were the predominant tumor
type.
Only one basal cell tumor was observed in the Matrix
SENCAR mice. Thisisinagreementwiththoseofother
investigators who report basal cell tumors are rare in
mice (19,20). The one basal cell tumornoted in our stud-
ies was a malignant lesion, comprising irregularly
round, basophilic cells arranged in dense packets.
Within several ofthe cell clusters, primitive sebaceous
differentiation was present.
The remainder of the neoplasms involving the skin
were primarily confined to the dermis and subcutis and,
FIGURE 11. Squamous cell carcinoma. Ulceration, typical of a car-
cinoma is present, but the elevated rim ofmalignant tissue at the
margins ofthe lesion is absent. Lesion was clinically diagnosed as
a sore (ulcer).
with few exceptions, were diagnosed clinically as sub-
cutaneous nodules. The vast majority of these lesions
were mammary gland neoplasms including both benign
and malignant neoplasms. Mammary gland neoplasms
in mice have been classified by predominant cell type
(26). The type-B mammary gland adenocarcinoma was
the most frequent type observed. Mixed adenocarci-
nomas and adenoacanthomas were also common.
Among the other neoplasms observed in the subcutis
were fibrosarcomas and rhabdomyosarcomas. With the
exception ofthe carcinosarcomas described previously,
the various sarcomas of the subcutis appeared to de-
velop totally independently ofthe superficial aspects of
the skin, and often only minimal epidermal changes ac-
companied the neoplasms. The incidence of the subcu-
taneous sarcomas was significantly increased in studies
in which treatment was administered either by subcu-
taneous or interperitoneal injection versus the topical
route of application. Only one plasma cell tumor was
observed in the Matrix mice. Grossly, this neoplasm
resulted in the irregular elevation of a substantial por-
tion ofthe dorsal skin. Although the skin generally re-
mained intact over the neoplasm, there was complete
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Table 2. Classification of pulmonary lesions in female SENCAR
mice.
Neoplasms Nonneoplastic lesions
Primary neoplasms of the lung Lymphoid infiltrates
Alveolar-bronchiolar adenoma (peribronchiolar and
Solid perivascular)
Papillary Inflammation, interstitial
Tubular Inflammation, granulomatous
Alveolar Histiocytosis
Mixed Myeloid hyperplasia
Alveolar-bronchiolar carcinoma Hyperplasia, alveolar lining cell
Squamous cell carcinoma Hyperplasia, bronchiolar lining
Secondary neoplasms of the lung cell
Mammary adenocarcinoma
Squamous cell carcinoma
Histiocytic sarcoma
Sarcoma, NOS
loss of hair and severe erythema. Microscopically,
loosely arranged sheets of plasma cells had infiltrated
the dermis and subcutis. This infiltration was accom-
panied by a mild to moderate hyperplasia of the epi-
dermis that consisted primarily of acanthosis. The ep-
idermis was interrupted by multiple erosions and
several small focal ulcerations.
Gross and Microscopic Lesions of the
Lung
The pathological findings in several of the studies
demonstrated an increased incidence of primary lung
tumors in the SENCAR mouse in response to several
known carcinogens as compared to that of vehicle con-
trols. In most cases, this response was dose related.
Based on these findings, Robinson and others (12) sub-
sequently used the SENCAR mouse in combined bioas-
say studies in which a modified Shimkin lung adenoma
assay and the skin papilloma assay were conducted si-
multaneously. During the past 30 months, the lungs
from approximately 3500 SENCAR mice were exam-
ined microscopically. This examination included the
lungs of mice used in combined bioassay studies and
other skin initiation-promotion studies in which abnor-
mal lung changes were recognized grossly. The various
types of lesions that we observed in the SENCAR
mouse lung are shown in Table 2.
Nonneoplastic Lesions ofthe Lung. Inflammatory
lesions were the most frequently observed nonneoplas-
tic changes observed in the lungs of SENCAR Matrix
mice. Theseinflammatory responses varied inboth mor-
phologic features and severity, and in several studies,
the changes were not always treatment and/or dose re-
lated. Inthis case, the lesions were nonspecific inorigin.
The most common lesion consisted ofrandomly distrib-
uted peribronchiolar and perivascular lymphocytic cel-
lular infiltrates that generally involved one to several
pulmonary airways and/or vessels. In some cases, the
collar lymphoid infiltrates extended into the adjacent
alveolar interstitium for short distances. Frequently, a
small population of plasma cells accompanied these le-
sions. Similar changes have been observed in other
stocks and strains of mice and we regarded these
changes ascommon, nonspecific, andincidentalfindings.
In several studies, the pulmonary response consisted
of a more severe, chronic-active interstitial inflamma-
tion. Lymphocytes, plasma cells, and macrophages in-
filtrated the interstitium and early fibrosis of the al-
veolar septa often occurred. Varying numbers offoamy
histiocytes occupied the alveolar spaces, and, occasion-
ally, fewer numbers of neutrophils and lymphocytes
were present. Associated withthesechangeswas amin-
imal to mild hyperplasia ofthe alveolar lining cells. The
morphologic features of these lesions were similar to
those described as being caused by infectious agents,
including Sendai infection (27). However, no definitive
agentwasidentifiedbyserologic examination ofsentinel
mice. These lesions, on gross examination, appeared as
poorly defined, irregularly round, tan foci, and, when
subpleural, they were slightly raised above the pleural
surface ofthe lung. These subpleural changes were dif-
ficult to distinguish from primary lung tumors on gross
examination and during the Shimkin counts.
Anothertype ofinflammatory response observed was
more granulomatous in nature and often included the
formation ofoneto severalgranulomas thathad varying
degrees oforganization. These lesionswere occasionally
quite large and were almost exclusively subpleural in
distribution. The presence of these lesions was re-
stricted to those mice which had severe skin ulcerations
and/or ulcerated skin tumors. In these animals, gran-
ulomas orchronicinflammatory infiltrates were alsofre-
quently found in the kidney and/or liver. These lesions
most likely represented a response to systemic infec-
tions that originated from the ulcerated skin. In the
lung, the well-organized subpleural granulomas were
routinelymisinterpreted as primarylungtumors inthat
they were generally tan, well circumscribed, and ele-
vated above the pleural surface of the lung, features
consistent with pulmonary adenomas.
Histiocytosis, in the absence of other inflammatory
response, was also a frequent observation in the lungs
of both treated and nontreated SENCAR mice. This
lesion, recognized routinely in other strains and stocks
ofmice, has been interpreted as an incidental, nonspe-
cific change often associated with older mice (28). The
lesions in the SENCAR mouse, in the absence ofother
inflammation orneoplasia, consisted oflarge histiocytes
(macrophages) with abundant grey foamy cytoplasm
and a single small dark nucleus. In mice with primary
lung neoplasms, aggregates of histiocytes were found
at the margins oftumors, especially in association with
alveolar-bronchiolar carcinomas. In these cases, the cy-
toplasm ofthe histiocytes was brightly eosinophilic and
the nucleus appeared pyknotic. The presence ofcells of
similar morphology have been reported in association
with alveologenic tumors in many strains of mice (28).
In the SENCAR mice, brightly eosinophilic histiocytes
were also found associated with small focal areas of
alveolar lining cell hyperplasia in which the alveolar
spaces contained both histiocytes and a homogenous,
proteinaceous material that most likely represented a
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secretory product. When these lesions had a subpleural
distribution, they were occasionally misinterpreted as
primary lung tumors.
Myeloid hyperplasia was observed in the lungs of
SENCAR mice that had severe, long-standing skin ul-
cers orulcerated neoplasms. Mature and immature cells
of the granulocytic series were found within alveolar
capillaries and major pulmonary vessels. These lesions
seldom had gross manifestations.
Hyperplasia of either alveolar lining cells and/or the
bronchiolar epithelium was a common observation.
These hyperplastic foci were most frequently observed
inassociationwithalveolarducts, andto alesserextent,
withterminalbronchioles. Theywereseldomsubpleural
in distribution. Some investigators have previously
classified the pulmonary hyperplasias by overall mor-
phologic pattern and have included types such as solid,
tubular, papillary, alveolar, etc. (29,30). The vast ma-
jority ofthe hyperplastic lesions observed in the SEN-
CAR lung were of the alveolar and/or papillary-mixed
types.
Neoplastic Lesions of the Lung. The morphologic
and histogenic classification of primary pulmonary tu-
mors in the mouse lung continues to be controversial.
Most pathologists involved in mouse carcinogenesis
studies have separated the alveolar-bronchiolar tumors
into adenomas and carcinomas. However, it isgenerally
accepted that pulmonary adenomas ultimately become
malignant (31,32). In the SENCAR Matrix mice, both
alveolar-bronchiolar adenomas and carcinomas were ob-
served, but the majority of the primary lung tumors
were adenomas. This finding was most likely influenced
by the age of the mouse and the time on study, since
all Matrix mice were sacrificed before 14months ofage,
with some studies terminated before 12 months. Ward
(29) and others (29-34) have classified the primary lung
tumors according to morphologic arrangement. Alveo-
lar, solid, papillary, tubular, and mixed typeshave been
identified. Inthe SENCAR Matrixmice, approximately
equal numbers ofsolid and papillary or papillary-mixed
tumors were observed. The solid alveolar-bronchiolar
adenomas were most frequently subpleural in distri-
bution and were easily discernible ongross examination
as pale, tan, well circumscribed, elevated nodules. Mic-
roscopically, these lesions consisted of tightly packed,
nonciliated cuboidal cells that rested on scanty amounts
offine reticulin stroma. The borders ofthese neoplasms
compressed the adjacent parenchyma and were often
poorlydefined andnonencapsulated. Themajorityofthe
papillary and/or papillary-mixed type adenomas were
associated with small airways. In some cases, it was
impossible to discern whether the tumors originated in
the bronchiole or if the neoplasm had grown into the
airway. In these lesions, the neoplastic cells were col-
umnar, devoid of cilia, and uniform in size and shape.
The borders of these lesions were also poorly defined.
Neoplastic elements feathered into the adjacent par-
enchymain amannerresemblinghyperplastic epithelial
growth.
The malignant primary lung tumors, alveolar-bron-
chiolar carcinomas, varied in size from small focal tu-
mors consisting of highly anaplastic cells to large neo-
plasms that effaced entire lung lobes. In large tumors,
it was not uncommon to see multiple morphologic pat-
terns in one lesion. The majority ofthe carcinomas ob-
served in the Matrix mice were mixed types and fre-
quently airway-associated. Our observations indicated
that the papillary- or papillary-mixed-type neoplasms
were more likely to become malignant lesions than the
subpleural solidtumors. Insomeofthesmallerpapillary
or mixed tumors, small foci of anaplastic cells usually
more basophilic than the adjacent tumor cells, were
observed as islands within a well-differentiated ade-
noma. These islands very likely represented malignant
transformation of the lung tumor, a finding previously
described by Mori (35). Mild to occasionally severe des-
moplastic response was associated with the larger car-
cinomas. Although vascular invasion by malignant cells
was present, no metastases to other organs were ob-
served.
The cell of origin for primary lung tumors in the
mousehasalsobeenmuchdebated. Untilrecently, most
investigators reported pulmonarytumors inthe mice as
arising from alveolar lining cells, more specifically, the
type-Il lining cell (28,31,32). However, the finding that
some of the neoplasms arose in or adjacent to airways
suggested that bronchiolar epithelial cells may be the
origin for some pulmonary tumors. Kaufman et al.
(33,34) first proposed the Clara cell as the cell oforigin
for tubular and/or papillary lesions that were most fre-
quently airway associated. Most recently, Ward (29,30)
used avidin-biotin immunocytochemical procedures to
localize surfactant apoprotein (SAP) and Clara cell an-
tigen (CCA) in both spontaneous and induced lung tu-
mors in several strains and stocks ofmice including the
SENCAR mouse. These investigators found that the
majority of the pulmonary tumors in the mouse were
immunoreactive to SAP, a marker for alveolar type-II
cells and that the Clara cell antigen could not be de-
tected in any lung tumors, even in the papillary or tu-
bular airway-associated tumors previously reported as
being of Clara cell origin (33,34). It appears that the
cell of origin for the solid, subpleural tumors and the
papillary or papillary-mixed airway-associated neo-
plasms describedinthe SENCAR Matrixmice, remains
controversial.
The only other primary lung neoplasm observed in
the SENCAR mice was a squamous cell carcinoma.
These tumors are extremely rare in mice (31) but have
been induced by a number of polycyclic aromatic hy-
drocarbons (32). The one squamous cell carcinoma ob-
served in the Matrix studies completely occupied one
lobe and extended into the adjacent pleura. Microscop-
ically, the neoplasm consisted of sheets of anaplastic
cells, and numerous mitotic figures were present. Un-
like previously reported squamous cell carcinomas (31),
the neoplasm in the Matrix study contained only small
amounts of poorly developed keratin with only limited
formation ofkeratinpearls. Morphologically, thistumor
resembled the foci of pulmonary squamous cell metas-
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tases that were present in several mice with skin car-
cinomas. However, in the mouse with the primary neo-
plasm, no neoplastic lesions were present in either the
skin or in the esophagus and forestomach.
Metastatic or secondary neoplasms involvingthe lung
were observedinseveraloftheMatrixmice. Metastases
from mammary gland neoplasms and malignant skin le-
sions were most frequently observed. In these cases,
the areas ofmetastases could not be differentiated, by
gross examination, from primary pulmonary tumors.
Correlation of Gross and Microscopic
Findings
During our discussion ofthe different types oflesions
involving the skin and lung of the SENCAR Matrix
mice, an attempt was made to define the gross and
microscopic morphologic features that were most com-
monly associated with specific lesions. As part of the
final pathology report that was generated for each Ma-
trix study, a correlation table that compared the gross
necropsy observations and the microscopic findings was
prepared. Recently, we expanded the correlation of
gross and microscopic data to include the clinical data
recorded at the last observation period before terminal
sacrifice. This observation occurred usually one week
and not more than one month before sacrifice. Although
a definitive statistical analysis of the correlation of the
final clinical observation and microscopic data was not
included in this report, a review ofthe clinical and mi-
croscopic data indicated that there were obvious short-
comings in the diagnostic accuracy of the gross obser-
vations.
It is our experience that even when the same per-
sonnel are used, their training maintained consistently,
and the diagnostic criteria well established, many squa-
mous cell skin neoplasms cannot be diagnosed accu-
ratelywhenonlygrosscriteriaare applied. Historically,
attempts to correlate gross and microscopic diagnoses
in skin initiation-promotion studies were neither per-
formed norreported, and whenprovided, the data were
generally limited toconfirmationofthoselesionsgrossly
determined tobecarcinomas. Ithasbeenourexperience
that there was a high correlation between the lesions
diagnosed grossly as squamous cell carcinomas and the
microscopic findings. In these cases, the type oftumor
and its malignant properties were generally easily rec-
ognizable. In one Matrix study, 18 ofthe 19 skin lesions
diagnosed grossly as squamous cell carcinomas were
microscopically confirmed as malignant neoplasms.
Hennings (36) recently reported that more than 90% of
the tumors diagnosed clinically as carcinomas were mic-
roscopically confirmed as squamous cell carcinomas. In
most ofthese reports, the microscopic confirmation was
limitedtothoselesionsdiagnosedgrosslyascarcinomas,
which may explain the low conversion rates of papillo-
mas to carcinomas that have been reported (37), since
many of the lesions may have had subtle malignant
changes that were not detected grossly and were never
examined microscopically.
Correlation of clinical observations with microscopic
findings also indicated that pedunculated squamous cell
papillomas were also accurately diagnosed by gross ex-
amination, especially ifthe lesions were palpated care-
fully. Thedatafromselectedstudiesexaminedindicated
that pedunculated squamous cell papillomas, as ob-
served at the final clinical observation point, were di-
agnosed with 92% accuracy (44 of 48 papillomas).
The diagnostic accuracy of gross observations de-
creased markedly when othertypes ofskin lesions were
considered, particularly sessile papillomas, keratoacan-
thomas, and lesions diagnosed as sores. Almost halfthe
sessile papillomas (12 of26) and keratoacanthomas (four
of ten) diagnosed grossly were microscopically con-
firmed tobe squamous cellcarcinomas. Sixoftenlesions
diagnosed grossly as sores were microscopically diag-
nosed as squamous cell carcinomas or carcinosarcomas.
The reduced clinical diagnostic accuracy for lesions of
this type can in part be explained by the fact that the
early malignant transformation in these lesions most
frequently occurred at the base of the lesion and was
hidden from gross observation. It was not until the neo-
plastic cells extended upward and to the margins ofthe
tumor was the malignant change appreciated grossly.
It appears that the poor clinical diagnostic accuracy of
lesionsofthistypeisnotlimitedto ourlaboratory. Ward
reported that in three studies examined, there were
three to four times more carcinomas diagnosed histo-
logically than were found clinically, and he recom-
mended that all skin tumors be examined microscopi-
cally when malignancy is a critical endpoint (30).
Figure 11 demonstrated a lesion diagnosed clinically
as a sore that was actually a carcinosarcoma. Ifthe rim
offleshymalignanttissueusuallypresentatthemargins
ofthe ulcerated portion ofa carcinomawas missing, the
lesions were inaccurately diagnosed as a sore. We did
observe that ifthe ulcerated lesion was dry and crusty,
the lesion was more often an ulcer with epithelial hy-
perplasia rather than neoplasia. Occasionally, a skin le-
sion was observed to have the gross appearance of a
small sessile papilloma (Fig. 12). Microscopically, how-
ever, although a superficial papilliferous protuberance
was present, the base ofthe tumor consisted ofa highly
malignantsquamouscellcarcinomathathadinvadedthe
subcutaneous muscle and body wall (Fig. 13). The an-
aplastic squamous cell carcinoma shown in Figure 9,
clinically diagnosed as a papilloma, consisted of a su-
perficialprotuberance (Fig. 14)thatwas consistent with
a papilloma. However, most ofthe lesion consisted ofa
highly anaplastic invasive carcinoma. It is unlikely that
thislesioncouldhavebeendiagnosedaccuratelywithout
atleast gross sectioning. Figure 15showsthemalignant
conversion ofa broad-based papilloma. In this case, the
change was too subtle for gross detection.
Similarly, Figure 16 demonstrates the base of a neo-
plasm in which multiple islands of malignant cells de-
veloped separately from the base ofthe rete ridges, the
areainwhichmalignanttransformation mostfrequently
occurred. Figure 17demonstrates evenmorevividlythe
frequent microscopic subtlety of malignant transfor-
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FIGURE 12. Squamous cell carcinoma. The lesion has the clinical
presentation of a sessile papilloma. The malignant transformation
at the base of the lesion was not observed grossly.
FIGURE 13. Squamous cell carcinoma. Microscopic appearance of
the neoplasm in Fig. 12. Papillary protuberances borderthe lesion
but there is invasion of the skin and body wall by the malignant
neoplasm at the base of the lesion (H & E, x52).
FIGURE 14. Squamous cell carcinoma. Lower magnification of ana-
plastic carcinoma in Fig. 9. The neoplasm had the superficial ap-
pearance of a typical, small papilloma (H & E, x52).
mation. Although junctional activity at the basement
membrane was indicated, the definitive diagnosis of
squamous cell carcinoma was made based on the two
small aggregates of malignant cells. Multiple sections
ofthis lesion were prepared, and in each, one or several
small aggregates of malignant cells was observed.
Similar gross versus microscopic correlation difficul-
ties were also encountered in studies of SENCAR Ma-
trix mice lungs. In particular, while the modified
Shimkin procedures were being performed as part of
the combined bioassay studies, inflammatory lesions
were misinterpreted as primary lung tumors. Sub-
pleural granulomas and focal areas ofchronic-active in-
terstitial inflammation were commonly misinterpreted
grossly as primary lung tumors, as were metastatic le-
sions from the skin, mammnary gland, and other tissues.
Accurate gross interpretation ofthe alveolar-bronchio-
lartumors was further compromised bythe distribution
of the primary lung tumors. Approximately half the
FIGURE 15. Squamous cell carcinoma. Malignant transformation at
the base (see arrow) of a sessile papilloma (H & E, x52).
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FIGURE 16. Squamous cell carcinoma. Several aggregates ofmalig-
nant squamous cells at the base of a papilloma (H & E, x 130).
lesions were loosely arranged papillary or papillary-
mixed, airway-associated adenomas located deep in the
lung parenchyma. This finding differs from those as-
sociated with the Strain A mouse routinely used in the
lung adenoma assay in that the vast majority of the
Strain A primary lung neoplasms were solid, well-de-
fined, subpleural nodules and were easily recognized
grossly (12-14). In one combined bioassay study in
which both SENCAR and Strain A mice were used,
only 30% of the lesions diagnosed grossly as tumors
could be microscopically confirmed as primary lungneo-
plasms. Routinely, more than 75% of the lung tumors
diagnosed grossly in the Strain A mice are microscop-
ically confirmed. Not only does the subpleural location
ofthemajorityofthe Strain Alesionsaidintheaccuracy
of the Shimkin procedures, but also the inflammation
present in the SENCAR mouse lung that frequently
compromised gross diagnosis was not present in the
Strain A mice. However, Robinson and others (12) have
- - rt
FIGURE 17. Squamous cell carcinoma. Subtle malignant transfor-
mation of a lesion at the base rete ridges. Note two small aggre-
gates ofmalignant cells separate from the ridges (H & E, x 130).
reported that after microscopic examination was per-
formed on the lungs of treated SENCAR mice, the
SENCAR mouse was only slightly less sensitive than
the Strain A mouse in response to several known car-
cinogens and was significantly more responsive than
other strains examined.
Conclusion
The gross and microscopic morphologic features of
the various treatment-induced and spontaneously oc-
curring lesions of the skin and lung of the SENCAR
mouse have been reviewed. With few exceptions, there
was generally poor correlation between the gross ob-
servations and the microscopic findings despite careful
clinical observation and palpation. For the most part,
gross versus microscopic discrepancies in the interpre-
tation ofskin lesions were attributed to the wide range
ofgross manifestations ofthe various lesions and to the
fact that when there was apparent malignant transfor-
mation of benign skin neoplasms, it most frequently
occurred at the base of the lesion and could not be de-
tected initially by gross observation. In the lung, non-
neoplastic treatment-associated, and spontaneous back-
ground lesions often compromised accurate gross
interpretation of primary lung tumors. However, the
results of combined bioassay studies indicated that the
SENCAR lung was responsive to several known car-
cinogens and that the SENCAR skin-lung tumor com-
bined bioassay merits further consideration.
Thismaterialhasbeenfunded whollyorinpartbythe United States
Environmental Protection Agency under contract 68-03-3170 to Pa-
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and it has been approved for publication as an EPA document. Men-
tion of trade names or commercial products does not constitute en-
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